Who
Minnie Baylor-Henry
Director
Company insider
Files Form 4 as: Director, Apyx Medical; Director, Lantheus Holdings; Director, scPharmaceuticals; Director, Paratek Pharmaceuticals; Director, Polarityte.
In numbers
- Trades disclosed
- 58
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $517
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 20 Jul 2018
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 7 Oct 2025filed 7 Oct 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code D | —30,000 at $0.00 | filing |
| 7 Oct 2025filed 7 Oct 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code D | —19,750 at $0.00 | filing |
| 7 Oct 2025filed 7 Oct 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code D | —16,300 at $0.00 | filing |
| 7 Oct 2025filed 7 Oct 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code D | —6,124 at $0.00 | filing |
| 7 Oct 2025filed 7 Oct 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,248 at $0.00 | filing |
| 3 Jun 2025filed 5 Jun 2025 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —59,000 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 15 Jan 2025filed 17 Jan 2025 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Aug 2024filed 12 Aug 2024 | APYX Apyx Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | scPharmaceuticalsoption or derivative | SEC FORM 4 Code A | —19,750 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,853 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,635 at $0.00 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,800 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticals | SEC FORM 4 Code D | —32,800 | filing |
News
No headline names them, or the companies they trade most, lately.